Jane Street Group, LLC Lipocine Inc. Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.3 - $0.58 $7,308 - $14,129	24,362 Added 147.59%	40,868 $13,000
Q4 2022 Feb 14, 2023	SELL	$0.37 - $8.65 $5,559 - $129,974	-15,026 Reduced 47.65%	16,506 $6,000
Q3 2022 Nov 14, 2022	BUY	$0.49 - $7.65 $2,281 - $35,618	4,656 Added 17.32%	31,532 $14,000
Q2 2022 Aug 16, 2022	SELL	$0.73 - $1.34 $2,834 - $5,203	-3,883 Reduced 12.62%	26,876 $22,000
Q1 2022 May 17, 2022	BUY	$0.89 - $1.85 $7,227 - $15,023	8,121 Added 35.87%	30,759 $42,000
Q4 2021 Feb 15, 2022	SELL	$0.99 - $1.2 $14,695 - $17,812	-14,844 Reduced 39.6%	22,638 $22,000
Q3 2021 Nov 16, 2021	BUY	$1.08 - $1.49 $40,480 - $55,848	37,482 New	37,482 $41,000
Q2 2021 Aug 16, 2021	SELL	$1.17 - $1.59 $34,000 - $46,205	-29,060 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$1.38 - $2.28 $40,102 - $66,256	29,060 New	29,060 $44,000

Ticker LPCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,510,800
Market Cap $434M
Description
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.